One of the nation’s leading pediatric hospitals to adopt GPS Cancer™, a
comprehensive molecular testing platform for personalized cancer
therapy, for its patients and self-insured employee population
NantHealth’s decision support, patient engagement, care coordination,
and analytics solutions to help Phoenix Children’s advance population
health and improve value-based outcomes
CULVER CITY, Calif.--(BUSINESS WIRE)--
NantHealth,
Inc., (Nasdaq: NH), a leading next-generation, evidence-based,
personalized healthcare company, announced today that Phoenix Children’s
Hospital, one of the leading children’s hospitals nationwide and
founding member of the Cancer
MoonShot 2020 Pediatrics Consortium, has entered into a commercial
licensing agreement for NantHealth’s suite of precision medicine and
healthcare IT solutions. These include GPS
Cancer™, the leading molecular test for personalized cancer therapy,
the eviti®
oncology decision support platform, named #1
Clinical Decision Support solution for 2016 by Black Book Market
Research, and NantHealth’s patient
engagement, care
coordination, and analytics
solutions built on NantOS™,
the industry’s leading cloud-based, healthcare platform.
Adoption of GPS Cancer™ for pediatric patients and employees
Under the terms of the agreement, Phoenix Children’s Hospital will
leverage the power of GPS Cancer, a molecular test integrating whole
genome (DNA) sequencing, whole transcriptome (RNA) sequencing, and
quantitative proteomics in two ways. First, its network of oncologists
will be able to order GPS Cancer, enabling them to gain critical
insights to inform personalized treatment strategies including guided
chemotherapies, FDA-approved targeted drugs, and active clinical trials
for their pediatric cancer patients. Second, Phoenix Children’s Hospital
will cover GPS Cancer for its employees and their families, making it
one of the nation’s first self-insured employers to cover proteogenomic
sequencing for a variety of cancers.
Adoption of healthcare IT solutions for precision cancer care
In addition, by combining GPS Cancer with NantHealth’s software
portfolio, Phoenix Children’s Hospital will be able to more easily
manage and coordinate care for its patient population, thereby helping
to improve engagement, reduce costs, and deliver on value-based
outcomes. NantHealth’s solutions to be deployed at Phoenix Children’s
Hospital include those for:
-
Oncology decision support: Through the eviti decision support
platform, oncologists will have access to evidence-based regimens,
condition-specific clinical trials options, and capabilities to
streamline preauthorization in advance of cancer treatments. With
eviti, Phoenix Children’s joins over 75 percent of U.S. oncology
practices who have adopted eviti platform to make better clinical
decisions earlier in the treatment process.
-
Patient engagement: With the NantHealth
Patient Portal, patients will be able to access test results,
expedite appointment scheduling, and securely communicate with Phoenix
Children’s Hospital doctors through a web-based interface, enabling
them to be more fully engaged with their care teams. In addition, the Health
Heritage web application will allow patients to easily collect and
share their family health histories with families and providers to
improve care decision-making.
-
Care coordination: The NantHealth
Provider Portal will equip Phoenix Children’s Hospital providers
with unified access to a 360° view of the patient across disparate
locations and episodes of care. Through the NantHealth
Referral Management application, doctors and administrators will
be able to transform a tedious referral processes into a streamlined
workflow connecting multiple sources of information and facilities
into a single referral resource. Finally, the NantHealth
Care Coordination application will help enable seamless
collaboration across care settings, including post-discharge care
coordination, urgent care triage, wellness programs, and transition of
care.
-
Analytics and Clinical Learning: NantHealth’s analytics and
clinical learning solutions, including the NantHealth
Outcomes Analytics and NantHealth
Value Monitor applications, will enable Phoenix Children’s
Hospital to measure and monitor key provider performance metrics to
drive continuous improvement initiatives through rich dashboards.
"NantHealth’s GPS Cancer test and expansive healthcare IT portfolio
provides us with the rich set of clinical and technical solutions to
deliver the most advanced care possible for our patients,” said Robert
L. Meyer, President and CEO, Phoenix Children’s Hospital. "With GPS
Cancer, our network of oncologists will be able to gain insight into the
most appropriate, personalized cancer therapies before treatment begins,
while NantHealth’s oncology decision support, patient engagement, and
care coordination solutions will help our care teams become more
efficient—in service of our patients—as we continue to move into a
value-based world.”
Mr. Meyer continued, “In addition, our organization’s commitment to
utilizing the GPS Cancer test for our employees, and their loved ones
who may be facing cancer diagnoses, is important to us as we work to
discover new potential therapies and clinical trials for cancer patients
in our community.”
"We are excited about this ground-breaking partnership with Phoenix
Children’s Hospital, and look forward to helping their oncologists make
better, more informed care decisions," said Patrick Soon-Shiong, MD, CEO
of NantHealth. “The fight against cancer and other life-threatening
diseases needs to be a collaborative effort that deeply integrates all
aspects of our healthcare ecosystem. By combining GPS Cancer with
best-in-class healthcare IT, we stand a better chance of understanding a
patient’s cancer before therapy begins, while ensuring providers have
all the tools they need to effectively manage their patient populations
and coordinate care across the continuum. Combined, these capabilities
deliver on NantHealth’s 10-year vision of integrating our complex
healthcare ecosystem as a real-time, adaptive learning system, and I am
excited about the leadership that Phoenix Children’s Hospital has taken
to achieve this critical mission.”
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, among others, statements regarding the capabilities and
anticipated utility of our GPS Cancer, including predicting patient
response and resistance to therapeutics, enabling diagnoses by
physicians and accelerating efforts to bring novel combinations of
therapeutic agents to cancer patients, as well as our contribution to
the Cancer 2020 initiative. Forward-looking statements are subject to
numerous risks and uncertainties that could cause actual results to
differ materially from currently anticipated results. Factors that may
cause future results to differ materially from management’s current
expectations include, among other things, that GPS Cancer may not
perform as anticipated, that sufficient physicians may not adopt GPS
Cancer to assist their diagnoses or that healthcare payers may not
provide reimbursement for GPS Cancer as expected. Our business is
subject to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our ability
to successfully launch new products and applications; competition; our
sales, marketing and distribution capabilities; our planned sales,
marketing, and research and development activities; unanticipated
increases in costs or expenses; and risks associated with international
operations. Information on these and additional risks, uncertainties,
and other information affecting our business and operating results can
be found in our existing and future filings with the Securities and
Exchange Commission. These forward-looking statements speak only as of
the date hereof. We disclaim any obligation to update these
forward-looking statements except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc. a member of the
NantWorks ecosystem of companies, is a next-generation, evidence-based,
personalized healthcare company enabling improved patient outcomes and
more effective treatment decisions for critical illnesses. NantHealth‘s
unique systems-based approach to personalized healthcare applies novel
diagnostics tailored to the specific molecular profiles of patient
tissues and integrates this molecular data in a clinical setting with
large-scale, real-time biometric signal and phenotypic data to track
patient outcomes and deliver precision medicine. For nearly a decade,
NantHealth has developed an adaptive learning system, CLINICS, which
includes its unique software, middleware and hardware systems
infrastructure that collects, indexes, analyzes and interprets billions
of molecular, clinical, operational and financial data points derived
from novel and traditional sources, continuously improves
decision-making and further optimizes our clinical pathways and decision
algorithms over time. For more information please visit www.nanthealth.com
and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
About Phoenix Children’s Hospital
Phoenix Children’s
Hospital, ranked in U.S. News & World Report’s Best Children’s
Hospitals, is Arizona’s only licensed children’s hospital, providing
world-class inpatient, outpatient, trauma, emergency and urgent care to
children and families in Arizona and throughout the Southwest. As one of
the largest children’s hospitals in the country, Phoenix Children’s
provides care across more than 75 pediatric specialties. The Hospital is
poised for continued growth in quality patient care, research and
medical education. For more information about the Hospital, visit www.phoenixchildrens.org.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160907005987/en/
NantWorks
Jen Hodson, 562-397-3639
jhodson@nantworks.com
or
Phoenix
Children’s Hospital
Lia Steinberg, 602-933-1091
lsteinberg@phoenixchildrens.com
Source: NantHealth, Inc.